These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34660518)

  • 1. Prevalence of Covid-19 Associated Symptoms, Their Onset and Duration, and Variations Among Different Groups of Patients in Bangladesh.
    Amin MT; Hasan M; Bhuiya NMMA
    Front Public Health; 2021; 9():738352. PubMed ID: 34660518
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of the primary presenting symptoms and hematological findings of COVID-19 patients in Bangladesh.
    Mohiuddin Chowdhury ATM; Karim MR; Mehedi HH; Shahbaz M; Chowdhury MW; Dan G; He S
    J Infect Dev Ctries; 2021 Mar; 15(2):214-223. PubMed ID: 33690203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical Characteristics of Mild-Moderate COVID-19 Patients and Risk Factors for the Development of Pneumonia].
    Özdemir YE; Balkan İİ; Bayramlar OF; Alkan S; Murt A; Karaali R; Mete B; Kuşkucu MA; Aygün G; Keskindemirci Y; Öngören Ş; Kutlubay Z; Çetinkale O; Saltoğlu N; Tabak F
    Mikrobiyol Bul; 2021 Jul; 55(3):342-356. PubMed ID: 34416801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demographic and Clinical Profile of COVID-19 ICU Patients of Bangabandhu Sheikh Mujib Medical University, Bangladesh.
    Mondal MK; Jahan S; Yeasmeen S; Haque AF; Habibullah M; Hasan M; Banik D
    Mymensingh Med J; 2021 Oct; 30(4):1117-1123. PubMed ID: 34605485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and impact of comorbidities on disease prognosis among patients with COVID-19 in Bangladesh: A nationwide study amid the second wave.
    Sharif N; Opu RR; Ahmed SN; Sarkar MK; Jaheen R; Daullah MU; Khan S; Mubin M; Rahman H; Islam F; Haque N; Islam S; Khan FB; Haque N; Ayman U; Shohael AM; Dey SK; Talukder AA
    Diabetes Metab Syndr; 2021; 15(4):102148. PubMed ID: 34186349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in COVID-19 symptoms and outcomes in people with kidney failure treated with dialysis: a prospective cohort study.
    Harrison TG; Tam TA; Elliott MJ; Ahmed SB; Riehl-Tonn V; Swamy AKR; Benham JL; Peterson J; MacRae JM
    J Nephrol; 2023 Apr; 36(3):851-860. PubMed ID: 36087218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should COVID-19 symptoms be used to cohort patients in the emergency department? A retrospective analysis.
    Bijur PE; Friedman BW; Baron SW; Ramasahayam A; Nerenberg R; Sharpe S; Goldstein DY; Esses D
    Am J Emerg Med; 2022 Apr; 54():274-278. PubMed ID: 35220142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 symptoms, duration, and prevalence among healthcare workers in the New York metropolitan area.
    Ganz-Lord FA; Segal KR; Rinke ML
    Infect Control Hosp Epidemiol; 2021 Aug; 42(8):917-923. PubMed ID: 33213542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Symptoms Prognostic of COVID-19 Severity: Multivariate Data Analysis of a Case Series in Henan Province.
    Li J; Chen Z; Nie Y; Ma Y; Guo Q; Dai X
    J Med Internet Res; 2020 Jun; 22(6):e19636. PubMed ID: 32544071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In COVID-19 Patients, the Identified Gastrointestinal Symptoms in Tertiary Care Center of India.
    Murugesan M; Govindarajan R; Prakash L; Murugan CK; Jasmine JJ; Krishnasamy N
    Euroasian J Hepatogastroenterol; 2022; 12(1):24-30. PubMed ID: 35990860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing a sentinel surveillance system for the novel COVID-19 in a resource-limited country: methods, system attributes and early findings.
    Das P; Akhtar Z; Mah-E-Muneer S; Islam MA; Rahman MZ; Rahman M; Rahman M; Rahman M; Billah MM; Alamgir A; Flora MS; Shirin T; Banu S; Chowdhury F
    BMJ Open; 2021 Dec; 11(12):e055169. PubMed ID: 34857579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is taste and smell impairment irreversible in COVID-19 patients?
    Salcan İ; Karakeçili F; Salcan S; Ünver E; Akyüz S; Seçkin E; Cingi C
    Eur Arch Otorhinolaryngol; 2021 Feb; 278(2):411-415. PubMed ID: 33432396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of non-intensive care unit COVID-19 patients in Saudi Arabia: A descriptive cross-sectional study.
    Al-Omari A; Alhuqbani WN; Zaidi ARZ; Al-Subaie MF; AlHindi AM; Abogosh AK; Alrasheed AK; Alsharafi AA; Alhuqbani MN; Salih S; Alhedaithy MA; Abdulqawi R; Ismail AF; Alhumaid S; Hamdan N; Saad F; Olhaye FA; Eltahir TA; Alomari M; Alshehery M; Yassiri A; Al-Tawfiq JA; Al Mutair A
    J Infect Public Health; 2020 Nov; 13(11):1639-1644. PubMed ID: 33004305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical presentation and mortality in hospitalized patients aged 80+ years with COVID-19-A retrospective cohort study.
    Karlsson LK; Jakobsen LH; Hollensberg L; Ryg J; Midttun M; Frederiksen H; Glenthøj A; Kodahl AR; Secher-Johnsen J; Nielsen LK; Bofill NG; Knudtzen FC; Lund CM
    Arch Gerontol Geriatr; 2021; 94():104335. PubMed ID: 33476754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and predictors of post-COVID-19 symptoms in general practice - a registry-based nationwide study.
    Hetlevik Ø; Wensaas KA; Baste V; Emberland KE; Özgümüs T; Håberg SE; Rortveit G
    BMC Infect Dis; 2023 Oct; 23(1):721. PubMed ID: 37880583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.
    Jeong TH; Pak C; Ock M; Lee SH; Son JS; Jeon YJ
    J Korean Med Sci; 2020 Sep; 35(37):e333. PubMed ID: 32959547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of ABO blood groups with presentation and outcomes of confirmed SARS CoV-2 infection: A prospective study in the largest COVID-19 dedicated hospital in Bangladesh.
    Mahmud R; Rassel MA; Monayem FB; Sayeed SKJB; Islam MS; Islam MM; Yusuf MA; Rahman S; Islam KMN; Mahmud I; Hossain MZ; Chowdhury AH; Kabir AKMH; Ahmed KGU; Rahman MM
    PLoS One; 2021; 16(4):e0249252. PubMed ID: 33826648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome evaluation of COVID-19 infected patients by disease symptoms: a cross-sectional study in Ilam Province, Iran.
    Sadeghifar J; Jalilian H; Momeni K; Delam H; Sheleme T; Rashidi A; Hemmati F; Falahi S; Arab-Zozani M
    BMC Infect Dis; 2021 Sep; 21(1):903. PubMed ID: 34479500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics.
    Speth MM; Singer-Cornelius T; Oberle M; Gengler I; Brockmeier SJ; Sedaghat AR
    Otolaryngol Head Neck Surg; 2020 Jul; 163(1):114-120. PubMed ID: 32423357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ear nose throat-related symptoms with a focus on loss of smell and/or taste in COVID-19 patients.
    Sakalli E; Temirbekov D; Bayri E; Alis EE; Erdurak SC; Bayraktaroglu M
    Am J Otolaryngol; 2020; 41(6):102622. PubMed ID: 32629147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.